
Reconstitution

Weight & Metabolism · 10mg
CAS 1627580-64-6
MOTS-c, also written MOTSc or MOTS c, is a mitochondrial-derived peptide (encoded within mitochondrial DNA) studied for metabolic flexibility, insulin-sensitivity, mitochondrial, and exercise-adaptation research. It belongs to a class of peptides encoded by the mitochondrial genome rather than the nucleus, and it is studied for how it engages the metabolic and exercise-adaptation pathways associated with that origin. The 10mg vial is the standard reference format.In preclinical and in-vitro research, MOTS-c is investigated for its role in metabolic-flexibility, insulin-signalling, and exercise-adaptation models, with research interest in how a mitochondrially encoded peptide communicates with the rest of the cell. Its mitochondrial-DNA origin is the defining research characteristic and the reason it is studied as a distinct metabolic-signalling reference.MOTS-c sits in the metabolism family and the wider energy-and-longevity range; researchers studying mitochondrial and metabolic pathways often look at it alongside NAD+ and SS-31. Our library covers the cellular-energy pathways these compounds are studied for. The 10mg vial here is the clean single-compound reference for MOTS-c.Every 10mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the inside wall of the vial, swirl gently, and never shake. Store the unopened vial at 2 to 8°C; refrigerate once reconstituted and do not refreeze. CAS reference 1627580-64-6.Buying MOTS-c in Australia is domestic: free Australia Post Express shipping to every state and territory, no minimum spend, dispatch from within Australia, and tracking on every parcel. Checkout accepts card, PayPal, or PayID, each vial is sealed under argon, and a 24-hour reservation holds your stock from order. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.
MOTS-c carries 267 indexed publications, 4 registered trials, 4,712 monthly readers on Wikipedia. Research activity sits at 55 papers in the past twelve months against 46 the year before.
Mitochondrial and metabolism-adjacent searches from more advanced shoppers.
267 papers, 55 this year · 4 trials · 4,712 readers (-6%) · B tier
Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.
Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.
MOTS-c 10mg arrives sealed and research-ready, with a written preparation and storage card in every order. Prepare and store it as set out below, and use the reconstitution calculator to work out your concentration and draw volume before you begin.
Your MOTS-c 10mg vial arrives securely packaged. Refrigerate it sealed at 2–8°C until you are ready to prepare.
Add Bacteriostatic Water slowly against the vial wall, then swirl gently. Never shake.
Once prepared, aliquot and freeze at −20°C. Avoid repeated freeze–thaw cycles.
“Pristine vial, sealed and clearly labelled. Arrived faster than the estimate.”
“Fast dispatch, full tracking, and tidy discreet packaging. Exactly as described.”
“Great quality and packaging. Tracking was a little slow to start but delivery was on time.”
Educational and product-logistics information only. Nothing here is medical advice or a therapeutic claim.
The coenzyme at the centre of cellular energy, what NAD+ is, how it differs from a peptide, and why it sits in the cellular-energy family.
Read →Research-grade retatrutide pricing per vial, per larger format, and per milligram, with a comparison to what a future pharmacy supply might look like.
Read →Two of the most studied metabolic peptides compared, receptor targets, research context, and what the difference means in practice.
Read →Also Searched As·MOTS-c is also searched as MOTS-c, MOTSc, MOTS c, Mitochondrial ORF peptide, MOTS-c peptide.
MOTS-c appears in 267 indexed publications going back to 2015, including 55 in the past twelve months. 4 registered trials appear on ClinicalTrials.gov.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 4 |
|---|---|
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 13 |
| 2019 | 22 |
| 2020 | 14 |
| 2021 | 31 |
| 2022 | 22 |
| 2023 | 35 |
| 2024 | 32 |
| 2025 | 46 |
| 2026 | 41 |